Helix BioPharma (TSE:HBP) Share Price Crosses Above 50-Day Moving Average - Here's What Happened

Key Points

• Helix BioPharma Corp. (TSE:HBP) has crossed above its 50-day moving average of C$0.95, reaching a trading high of C$1.05.
• The company, focused on cancer drug development, has a market cap of C$55.67 million and is currently experiencing a trading volume of 28,400 shares.
• Helix BioPharma is engaged in developing immuno-oncology therapies, with pipeline candidates including L-DOS47 and V-DOS47.

Helix BioPharma Corp. (TSE:HBP - ) crossed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of C$0.95 and traded as high as C$1.05. Helix BioPharma shares last traded at C$1.05, with a volume of 28,400 shares.

Helix BioPharma Trading Up 1.0%

The company has a market cap of C$55.67 million, a price-to-earnings ratio of -1.10 and a beta of -0.84. The firm's fifty day simple moving average is C$0.95 and its 200 day simple moving average is C$0.90.

Helix BioPharma Company Profile

Helix BioPharma Corp is a clinical-stage biopharmaceutical company. It is focused on cancer drug development. The company develops therapies in the field of immuno-oncology based on its proprietary technology mainly in the areas of cancer prevention and treatment. Its pipeline candidates are Tumor Defence Breaker L-DOS47, and, V-DOS47 among others.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.